Envoy Medical Advances Acclaim Cochlear Implant Trial
WHITE BEAR LAKE, Minn., July 21, 2026 Envoy Medical announced that all 56 patients enrolled in its pivotal clinical...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WHITE BEAR LAKE, Minn., July 21, 2026 Envoy Medical announced that all 56 patients enrolled in its pivotal clinical...
WHITE BEAR LAKE, Minn., Dec. 10, 2025 — Envoy Medical announced the successful first set of activations in the...
November 18, 2025 — Austin, Texas — Envoy Medical, Inc. announced it has successfully enrolled its first 10 patients...
ST. PAUL, Minn., Oct. 8, 2025 — Envoy Medical, a pioneer in fully implanted hearing device technology, has received...
